Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Blocking JAK-STAT signaling can lead to hair growth.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

PRP therapy helps heal pediatric surgical wounds faster and with fewer scars but needs more research for safety and cost.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Minoxidil effectively treats female pattern hair loss.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.